Tem Innovations GmbH encompasses the development and production of ROTEMÂ®
point-of-care diagnostics. The subsidiary
company Tem International GmbH
handles the distribution, marketing and
customer service for this product.
Both companies are committed to increase
the availability of perioperative coagulation
diagnostics like rotational thromboelastometry
(ROTEMÂ®), a technology known to simplify
and accelerate the management of acute
and massive bleeding situations.
The optimization of bleeding- and transfusion management with the goal to improve patient treatment and realize cost savings will become a key challenge in modern patient care in the future.
By consistently pursuing our customer-oriented research and development projects and through cooperation with appropriate partners, we achieve a leading market position for optimally adapted diagnostic products for effective bleeding management at the patients' point of care.
To find out more >download our company brochure.